Cellply
Unravelling immune system function, one cell at a time
Italy
34 employees
Undisclosed
Total: $17.44M
Biotechnology, Health Care
General Information
Get notified when Cellply moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Cellply
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Italy Market
Biotechnology
About Cellply
Taxonomy: life science, analytical tools, cancer immunotherapies, cell therapies, biotherapeutics, R&D acceleration, clinical response monitoring, microfluidic technologies, AI-powered analytics, single-cell analysis, Co-Culture Array technology, drug testing, potency evaluation, immune system function
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Undisclosed | •••••• | 5 |
|
11 May 2026 |
| Venture Round | •••••• | 3 |
|
27 Sep 2023 |
| Venture Round | •••••• | 5 |
|
15 Dec 2021 |
| Grant | •••••• | - | 22 Nov 2018 | |
| Grant | •••••• | 1 | •••• •••• | 25 May 2018 |
Latest News
View All
Cellply Alternatives & Competitors
Pioneering the future of cancer immunotherapy with CAR-T cell advancements from academic innovation.
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and ot...
Reimagining Cancer Immunotherapy
FAQ About Cellply
Don't just browse. Track.
Signal Tracker monitors Cellply and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
